Komodo Partners with Nasdaq for Enhanced Healthcare Investment Insights
NEW YORK, May 06, 2025–(BUSINESS WIRE)–Komodo Health, recognized for its expertise in real-world data and healthcare analytics, has entered into a collaboration with Nasdaq Data. This alliance aims to furnish hedge funds, private equity firms, and venture capital entities with comprehensive insights into the pharmaceutical sector and the U.S. healthcare landscape via the Nasdaq Medical Claims Insights (NMCI) dataset.
Access to Comprehensive Healthcare Data
The NMCI dataset, derived from Komodo’s Healthcare Map, stands out as an extensive repository of real-world data that facilitates the understanding of payer and provider dynamics, disease prevalence, patient care trends, and prescription behaviors. This resource equips market participants with the ability to monitor industry trends, project revenues at both drug and company levels, evaluate shifts in market shares, and identify emerging pharmaceuticals and enterprises. As a unique offering from Nasdaq, NMCI delivers a thorough overview of the U.S. healthcare ecosystem, capturing over 330 million longitudinal and real-time patient journeys across healthcare providers (HCPs), healthcare organizations (HCOs), and various care settings. The dataset encompasses detailed patient journey information, including prescriptions, specialty drugs, clinical records, electronic health records, payers, and laboratory data, all while ensuring patient anonymity by excluding any identifiable personal information.
Empowering Investors with Unique Insights
“Our collaboration with Nasdaq Data equips market participants with a distinctive dataset that enhances their analytical capabilities and investment strategies within the healthcare sector,” stated Miles Ennis, Chief Revenue Officer of Komodo Health. “By utilizing our AI-driven platform, users gain access to an unmatched variety, quality, and coverage of data that is essential for making informed decisions in a rapidly evolving market.”
Unlocking New Opportunities in Healthcare Investments
Brandon Tepper, Senior Vice President and Global Head of Data at Nasdaq, emphasized the value of this partnership: “The combination of Komodo’s extensive insights with our data capabilities and innovation has resulted in a unique dataset that offers an in-depth perspective of the pharmaceutical and U.S. healthcare sectors. The Nasdaq Medical Claims Insights will enable market participants to uncover new opportunities and make well-informed investment choices.”
About Komodo Health
Komodo Health is a technology and healthcare insights firm that sets the standard for real-world data and analytics. By linking the most comprehensive and unbiased view of patient experiences with AI-enhanced software, Komodo effectively connects patient journeys to broader health outcomes. Serving stakeholders across life sciences, payers, providers, and developers, Komodo provides a significant advantage by facilitating quick and precise access to patient-centric insights, thereby promoting faster decision-making, improving operational workflows, closing care gaps, and alleviating disease burdens.
Disclaimer on Investment Advice
The information presented herein is intended solely for informational and educational purposes and should not be interpreted as investment advice regarding any specific security or overall investment strategy. Nasdaq, Inc. and its affiliates do not endorse any recommendations to buy or sell securities, nor do they guarantee the financial stability of any company. Statements relating to Nasdaq-listed firms or proprietary indices do not assure future performance, and actual results may significantly differ from those projected. Historical performance should not be viewed as indicative of future results. Investors are encouraged to conduct their own research and carefully assess companies before making investment decisions. Seeking counsel from a securities professional is highly recommended. © 2025. Nasdaq, Inc. All Rights Reserved.
